505 related articles for article (PubMed ID: 3062960)
1. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
Klaus D
Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme inhibitors in hypertension: a review.
Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
4. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
5. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition in renal and hypertensive disorders.
Götz R; Heidbreder E; Heidland A
Clin Physiol Biochem; 1990; 8 Suppl 1():25-32. PubMed ID: 2257721
[TBL] [Abstract][Full Text] [Related]
7. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
Khan NA; McAlister FA; Lewanczuk RZ; Touyz RM; Padwal R; Rabkin SW; Leiter LA; Lebel M; Herbert C; Schiffrin EL; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; DeChamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Campbell NR; Arnold M; Moe G; Hill MD; Jones C; Larochelle P; Ogilvie RI; Tobe S; Houlden R; Burgess E; Feldman RD;
Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
[TBL] [Abstract][Full Text] [Related]
8. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective studies and prospects of therapy for hypertension].
Maisch B; Brilla C; Kruse T; Noll B; Bethge C
Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
[TBL] [Abstract][Full Text] [Related]
10. [ACE inhibitors and the kidney].
Hörl WH
Wien Med Wochenschr; 1996; 146(16):450-3. PubMed ID: 9036682
[TBL] [Abstract][Full Text] [Related]
11. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
12. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension in chronic kidney disease.
Toto RD
Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
[TBL] [Abstract][Full Text] [Related]
14. Comparison of beta-blockade and ACE inhibitors in the treatment of hypertension.
Prichard BN; Saul PA
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S81-5. PubMed ID: 11527141
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
16. Diabetes and hypertension, the deadly duet: importance, therapeutic strategy, and selection of drug therapy.
Deedwania PC
Cardiol Clin; 2005 May; 23(2):139-52. PubMed ID: 15694743
[TBL] [Abstract][Full Text] [Related]
17. [Are non blood pressure effects of converting enzyme inhibitors important in arterial hypertension?].
Gosse P; Guillo P; Dallocchio M
Rev Prat; 1992 Dec; 42(20):2539-43. PubMed ID: 1299937
[TBL] [Abstract][Full Text] [Related]
18. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure, diabetes and diabetic nephropathy.
Chantrel F; Moulin B; Hannedouche T
Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
[TBL] [Abstract][Full Text] [Related]
20. [ACE inhibitors in the diagnosis and therapy of various forms of hypertension].
Greminger P; Siegenthaler W; Vetter W
Schweiz Med Wochenschr; 1988 Apr; 118(14):495-501. PubMed ID: 2897714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
